GLP-2 (T) 30mg

Specifications

• Chemical Name: GLP‑2 T30

• Classification: Synthetic Modified Dual‑Receptor Agonist Analog

• Amino Acid Length: 39 amino acids (lipidated analog)

• Structural Characteristics: Modified long‑acting peptide analog

• Physical Description: White to off‑white lyophilized powder

• Solubility: Soluble in aqueous diluents

• Quantity: 30mg per vial

• Purity: ≥99.8%

• Storage:

  • Store at −20°C (−4°F)

  • Protect from moisture and prolonged light exposure

  • After reconstitution, refrigerate at 2–8°C (36–46°F); use within 30 days

• Grade: Research Use Only — Not for human consumption, therapeutic, or diagnostic use

Research Focus Areas

• Dual GIP/GLP‑1 receptor agonism

• Metabolic regulation and energy‑balance studies

• Body‑weight, adiposity, and appetite‑modulation models

• Glucose homeostasis and HbA1c‑reduction research

• Gastrointestinal growth, mucosal repair, and epithelial‑cell proliferation

• Long‑acting peptide pharmacokinetics and lipidation‑enhanced stability

• Cardiovascular‑risk and cardiometabolic‑health investigations

Mechanistic Interest

GLP‑2 (T) is studied for its ability to:

• Activate both GIP and GLP‑1 receptors, producing synergistic metabolic effects

• Support significant reductions in body weight and fat mass in preclinical models

• Improve glycemic control, including reductions in HbA1c

• Enhance intestinal growth, nutrient absorption, and mucosal integrity

• Provide extended activity due to its lipidated 20‑carbon fatty diacid modification

• Potentially support cardiovascular health in metabolic‑disease research

Its dual‑agonist profile and long half‑life make GLP‑2 (T) a central compound in advanced metabolic, gastrointestinal, and incretin‑pathway research.

NOTICE

FOR LABORATORY RESEARCH USE ONLY. NOT FOR HUMAN CONSUMPTION.